The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to CSTI-500, Consynance Therapeutics’ oral treatment…
Articles by Patricia Inácio, PhD
Adults with Prader-Willi syndrome (PWS) who were given growth hormone (GH) therapy in childhood are more likely to continue…
Metabolic and bariatric surgery (MBS) can safely lead to sustained weight loss in Prader-Willi syndrome (PWS) patients, a meta-analysis shows.
Treatment with liraglutide along with an exercise and diet program eased excessive hunger in children and adolescents with Prader-Willi…
Sleep disturbances in people with Prader-Willi syndrome (PWS) are linked with psychosis-risk symptoms, a study reports. Psychosis refers to…
A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases…
Early treatment with growth hormone — before 1 year of age — was associated with better body composition and cognitive…
Saniona will pause the Phase 2b clinical trials testing Tesomet for people with Prader-Willi syndrome (PWS) and hypothalamic…
The U.S. Food and Drug Administration (FDA) has told Levo Therapeutics that an additional clinical trial will be necessary to confirm…
A new study is looking for participants to assess the impact of a behavioral training program for caregivers of children…